| OASIS(EM) NCT03836040 | Fase 3 | En marcha, sin reclutar |
| OASIS(CM) NCT03832998 | Fase 3 | Completado |
| EMBRACE NCT04252742 | Fase 4 | Completado |
| A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine NCT04825678 | Fase 4 | Completado |
| INTERROGATE NCT04265755 | Fase 4 | Completado |
| A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache NCT03971071 | Fase 4 | Completado |
| Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine NCT03912337 | Fase 4 | Interrumpido |
| A Controlled Trial of Erenumab in Migraine Prevention NCT03812224 | Fase 3 | Completado |
| To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients NCT02542605 | Fase 1 | Completado |
| A Safety and Efficacy Study to Evaluate AMG 334 in Migraine Prevention NCT02630459 | Fase 2 | Completado |
| A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention. NCT02174861 | Fase 2 | Completado |
| Treadmill Cardiovascular Safety Study of Erenumab (AMG 334) NCT02575833 | Fase 2 | Completado |
| Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy Females NCT02792517 | Fase 1 | Completado |
| STRIVE NCT02456740 | Fase 3 | Completado |
| ARISE NCT02483585 | Fase 3 | Completado |
| A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention NCT02066415 | Fase 2 | Completado |
| Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention NCT01952574 | Fase 2 | Completado |
| Ascending Multiple-Doses of Erenumab (AMG 334) in Healthy Adults and in Migraine Patients NCT01723514 | Fase 1 | Completado |
| Study of Erenumab (AMG 334) in Women With Hot Flashes NCT01890109 | Fase 1 | Completado |
| Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine Patients NCT01688739 | Fase 1 | Completado |